Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Montanuy, Helena"'
Autor:
Montanuy, Helena1 (AUTHOR), Camps-Fajol, Cristina1,2 (AUTHOR), Carreras-Puigvert, Jordi1,2,3 (AUTHOR), Häggblad, Maria4,5 (AUTHOR), Lundgren, Bo6 (AUTHOR), Aza-Carmona, Miriam7,8 (AUTHOR), Helleday, Thomas4 (AUTHOR), Minguillón, Jordi1,3,9 (AUTHOR), Surrallés, Jordi1,2,3,9 (AUTHOR) Jordi.surralles@uab.cat
Publikováno v:
Orphanet Journal of Rare Diseases. 6/30/2020, Vol. 15 Issue 1, p1-9. 9p.
Autor:
Boada, Montserrat, Atance, Mireia, Joda, Laura, Montanuy, Helena, Oller, Georgina, Rocafort, Eugenia, Vendrell, Josep M., Coroleu, Buenaventura
Publikováno v:
In Revista Internacional de Andrología January-March 2014 12(1):24-31
Autor:
Minguillón, Jordi, Ramírez, María José, Rovirosa, Llorenç, Bustamante Madrid, Pilar, Camps Fajol, Cristina, Ruiz de Garibay, Gorka, Shimelis, Hermela, Montanuy, Helena, Pujol, Roser, Hernandez, Gonzalo, Bogliolo, Massimo, Castillo, Pau, Soucy, Penny, Martrat, Griselda, Gómez, Antonio, Cuadras, Daniel, García, María J., Gayarre, Javier, Lázaro, Conxi, Benítez, Javier, Couch, Fergus J., Pujana, Miquel Angel, Surrallés, Jordi, CIMBA Consortium
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers; Volume 14; Issue 2; Pages: 353
Cancers, Vol 14, Iss 353, p 353 (2022)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Universidad de Barcelona
Cancers; Volume 14; Issue 2; Pages: 353
Cancers, Vol 14, Iss 353, p 353 (2022)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Simple Summary BRCA2 is an essential gene for DNA repair by homologous recombination and is often mutated in families at risk of breast and ovarian cancer. In this study we identified CDK5RAP3 tumor suppressor as a new BRCA2-interacting protein. CDK5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1def6fdd77514bd7fc23bc7a77f6a6b
http://hdl.handle.net/2445/183778
http://hdl.handle.net/2445/183778
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Montanuy, Helena, Camps-Fajol, Cristina, Carreras-Puigvert, Jordi, Häggblad, Maria, Lundgren, Bo, Aza-Carmona, Miriam, Helleday, Thomas, Minguillón, Jordi, Surrallés, Jordi
Additional file 3: Supplementary Figure 3. Cell cytometry gate analysis for micronuclei assay in FANCA-deficient LFA55 lymphoblastoid cell line. A) Forward scattering (FSC) versus side scattering (SSC). A gate is created to include events with 1/100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9313bcb4dc2536ca241a530ae43b7b1f
Autor:
Montanuy, Helena, Camps-Fajol, Cristina, Carreras-Puigvert, Jordi, Häggblad, Maria, Lundgren, Bo, Aza-Carmona, Miriam, Helleday, Thomas, Minguillón, Jordi, Surrallés, Jordi
Additional file 1: Supplementary Figure 1. FANCA exon 1 sequence from U2OS clones 2F8 (A) and 2G7 (B). Forward and reverse primers are shown in blue and yellow, respectively. Bold letters show first codon of the FANCA open reading frame in the exon (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30af589ed907ca1210eeff3f56ea412a
Autor:
Montanuy, Helena, Camps-Fajol, Cristina, Carreras-Puigvert, Jordi, Häggblad, Maria, Lundgren, Bo, Aza-Carmona, Miriam, Helleday, Thomas, Minguillón, Jordi, Surrallés, Jordi
Additional file 2: Supplementary Figure 2. Library chemical properties. Average chemical properties from the 4 libraries used: A and B, AlogP (partition coefficient, measures the hydrophobicity/lipophilicity); C, HBA (number of hydrogen bond acceptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad4d372ef975e2e40b06c1c4b4845e5d
Autor:
Minguillón J; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Ramírez MJ; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Rovirosa L; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Bustamante-Madrid P; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Camps-Fajol C; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Ruiz de Garibay G; Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Shimelis H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, USA.; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901, USA., Montanuy H; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Pujol R; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Hernandez G; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Bogliolo M; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Castillo P; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain., Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC G1E 6W2, Canada., Martrat G; Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Gómez A; Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Cuadras D; Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., García MJ; Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain., Gayarre J; Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain., Cimba, Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Benítez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, USA.; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901, USA., Pujana MA; Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Surrallés J; Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jan 12; Vol. 14 (2). Date of Electronic Publication: 2022 Jan 12.